Sukhvir Singh, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 115 Mall Dr, Hanford, CA 93230 Phone: 559-582-9000 |
Neelima Gondi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 450 North Greenfield Ave, Hanford, CA 93230 Phone: 559-816-3754 Fax: 559-583-4625 |
Mrs. Tasha Scott-tomlinson, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 224 W Lacey Blvd, Hanford, CA 93230 Phone: 559-583-8913 Fax: 559-583-0543 |
James Kuo, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 115 Mall Dr, Hanford, CA 93230 Phone: 559-582-9000 |
Joyce Lynn Ho, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 115 Mall Dr, Hanford, CA 93230 Phone: 559-582-9000 |
News Archive
Certain genetic variations may be linked to higher rates of tooth decay and aggressive periodontitis, according to two recently published papers by researchers at the University of Pittsburgh School of Dental Medicine and their collaborators.
Trust for America's Health and the Robert Wood Johnson Foundation today released a new report, Shortchanging America's Health: A State-By-State Look at How Public Health Dollars Are Spent, which finds federal spending for public health has been flat for nearly five years, while states around the country cut nearly $392 million for public health programs in the past year, which leaves communities around the country struggling to deliver basic disease prevention and emergency health preparedness services.
Bright Note Technologyâ„¢, which instantly populates all critical data on a patient chart, is now available across the entire spectrum of McKesson's ambulatory electronic health record (EHR) solutions for physician practices. This dynamic processing technology enables physicians and other providers to use their preferred charting style to capture data in a single screen note and, with one touch, synchronize searchable data across a complete chart.
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
› Verified 3 days ago